Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NASDAQ
NASDAQ
Alkermes Spins Off Oncology Business with $275M to Focus on Neuroscience
Alkermes Spins Off Oncology Business with $275M to Focus on Neuroscience
BioSpace
Alkermes
spinoffs
oncology
Mural Oncology
NASDAQ
Flag link:
Antibody biotech Abpro taps SPAC to get back on Nasdaq track 5 years after axed IPO
Antibody biotech Abpro taps SPAC to get back on Nasdaq track 5 years after axed IPO
Fierce Biotech
AbPro
IPOs
SPAC
NASDAQ
Flag link:
Device company HDL Therapeutics eyes public listing in $480m SPAC deal
Device company HDL Therapeutics eyes public listing in $480m SPAC deal
Pharmaphorum
Medtech
SPAC
HDL Therapeutics
NASDAQ
atherosclerotic plaques
Flag link:
Okyo Pharma withdraws offer to sell shares after just 3 days citing 'changing market conditions'
Okyo Pharma withdraws offer to sell shares after just 3 days citing 'changing market conditions'
Fierce Biotech
Okyo Pharma
NASDAQ
Flag link:
Apogee, Sagimet overshoot IPO expectation as both biotechs land on Nasdaq
Apogee, Sagimet overshoot IPO expectation as both biotechs land on Nasdaq
Fierce Biotech
NASDAQ
IPOs
Apogee Therapeutics
Sagimet Biosciences
Flag link:
South Korean biotech group spies US SPAC as route to Nasdaq
South Korean biotech group spies US SPAC as route to Nasdaq
Fierce Biotech
OSR Holdings
South Korea
SPAC
NASDAQ
Flag link:
Turnstone Biologics Files for $86M IPO Amid Financial Difficulties
Turnstone Biologics Files for $86M IPO Amid Financial Difficulties
BioSpace
Turnstone Biologics
IPOs
NASDAQ
Flag link:
Biotech consolidation continues as Nasdaq-listed Erytech merges with phage therapy developer
Biotech consolidation continues as Nasdaq-listed Erytech merges with phage therapy developer
Endpoints
Erytech
NASDAQ
Pferecydes
M&A
Flag link:
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
Motley Fool
Moderna Therapeutics
RSV
Bluebird Bio
NASDAQ
Flag link:
Elicio uses struggling Angion as route to Nasdaq ahead of cancer vaccine's phase 2 move
Elicio uses struggling Angion as route to Nasdaq ahead of cancer vaccine's phase 2 move
Fierce Biotech
Elicio Therapeutics
NASDAQ
cancer vaccines
clinical trials
Angion Biomedica
Flag link:
GE’s board finalizes healthcare spinoff
GE’s board finalizes healthcare spinoff
Medtech Dive
GE Healthcare
Medtech
NASDAQ
Flag link:
Three Biopharma Companies Heading to Nasdaq Through SPACs
Three Biopharma Companies Heading to Nasdaq Through SPACs
BioSpace
SPACs
NASDAQ
Apexigen
Benuvia
Scilex
Flag link:
Vaccine Stocks Are Rising, but This Biotech Is Monday's Big Nasdaq Winner
Vaccine Stocks Are Rising, but This Biotech Is Monday's Big Nasdaq Winner
Motley Fool
biotech stocks
NASDAQ
vaccines
Novavax
Moderna Therapeutics
Ocugen
Intra-Cellular Therapies
Caplyta
Flag link:
Amylyx takes its ALS program to Nasdaq, raising the stakes for the biotech's only drug
Amylyx takes its ALS program to Nasdaq, raising the stakes for the biotech's only drug
Endpoints
Amylyx
ALS
funding
NASDAQ
Flag link:
Italian cancer gene therapy biotech makes history with modest Nasdaq IPO
Italian cancer gene therapy biotech makes history with modest Nasdaq IPO
Endpoints
gene therapy
IPOs
NASDAQ
Genenta
Italy
Flag link:
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut
Fierce Biotech
Vaxxinity
IPOs
vaccines
immunotherapy
NASDAQ
Flag link:
First Day Trading a Letdown for LianBio in Shadow of Beijing Market Crackdown
First Day Trading a Letdown for LianBio in Shadow of Beijing Market Crackdown
BioSpace
LianBio
Beijing
IPOs
NASDAQ
Flag link:
Two Biopharmas Nix IPO Plans in Unstable Market
Two Biopharmas Nix IPO Plans in Unstable Market
BioSpace
NASDAQ
IPOs
AEON Biopharma
Cingulate
Flag link:
OrbiMed's TKI play makes its Nasdaq debut as Theseus prices IPO
OrbiMed's TKI play makes its Nasdaq debut as Theseus prices IPO
Endpoints
IPOs
Theseus Pharmaceuticals
OrbiMed
NASDAQ
Flag link:
Three more biotechs hit Nasdaq as the sector, now with more than $13B raised, continues barreling toward record
Three more biotechs hit Nasdaq as the sector, now with more than $13B raised, continues barreling toward record
Endpoints
IPOs
SPACs
NASDAQ
Pasithea Therapeutics
Tyra Biosciences
DiCE Therapeutics
Flag link:
Pages
1
2
3
4
5
6
7
next ›
last »